Pernille Ravn

Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age

David Hosking, Clair E.D. Chilvers, Claus Christiansen et al. · New England Journal of Medicine · 1998 · 487 citations · Full text

Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women

Pernille Ravn, Giovanni Cizza, N. H. Bjarnason et al. · Journal of Bone and Mineral Research · 1999 · 450 citations

Prevention of Bone Loss With Alendronate in Postmenopausal Women Under 60 Years of Age

David Hosking, Clair Chilvers, Claus Christiansen et al. · Obstetrical & Gynecological Survey · 1998 · 211 citations

Literary Theory, Clair E. D., Gynecology +17

Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study

Yu Z. Bagger, László B. Tankó, Peter Alexandersen et al. · Bone · 2004 · 186 citations

Bone Disease, Bone Health, Hormone Replacement Treatment +11

Alendronate and Estrogen–Progestin in the Long-Term Prevention of Bone Loss: Four-Year Results from the Early Postmenopausal Intervention Cohort Study: A Randomized, Controlled Trial

Pernille Ravn, Marianne Bidstrup, Richard D. Wasnich et al. · Annals of Internal Medicine · 1999 · 186 citations